Dr. Reddy's Laboratories Ltd. Fundamental & Technical Research, Share Price Today

NSE : DRREDDY
NIFTY : Nifty 50
NIFTY SECTOR : Nifty Pharma

About Company

Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is currently a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.

Market Cap. ₹96,083 Cr.

52 Week - High/Low ₹1,421/1,092

P/E Ratio 4.26

P/B Ratio 3.96

Enterprise Value ₹95,447 Cr.

ROE % 19.54

RSI Value 45.88

EMA 50 1184.52

EMA 200 1236.5

Net Profit 4,342 Cr.

Net Profit 3year growth 98.59 Cr.

Net Profit 3 year (back) 2,186 Cr.

Debt to Equity 0.03 %

EPS Growth TTM 24.93 %

Current Ratio 3.21 %

100 Day SMA 1,233 Rs.

200 Day SMA 1,280 Rs.

21 Day SMA 1,149 Rs.

50 Day SMA 1,180 Rs.

Book Value 290 Rs.

EV/EBITDA Ratio 12

QoQ EPS Growth -55 %

QoQ Operating Profit Growth -56 %

QoQ Sales Growth -25 %

Sales Latest Quarter 4,778 Cr.

YoY Sales Growth 22 %

Market Cap. ₹96,083 Cr.

52 Week - High/Low ₹1,421/1,092

P/E Ratio 4.52

P/B Ratio 3.40

Enterprise Value ₹94,319 Cr.

ROE % 21.76

RSI Value 45.88

EMA 50 1184.52

EMA 200 1236.5

Net Profit 5,578 Cr.

Net Profit 3year growth -0.78 Cr.

Net Profit 3 year (back) 1,952 Cr.

Debt to Equity 0.07 %

EPS Growth TTM 2.72 %

Current Ratio 2.59 %

100 Day SMA 1,233 Rs.

200 Day SMA 1,280 Rs.

21 Day SMA 1,149 Rs.

50 Day SMA 1,180 Rs.

Book Value 339 Rs.

EV/EBITDA Ratio 10

QoQ EPS Growth 13 %

QoQ Operating Profit Growth 9 %

QoQ Sales Growth 4 %

Sales Latest Quarter 7,996 Cr.

YoY Sales Growth 16 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages